Janux Therapeutics, Inc.JANXNASDAQ
LOADING
|||
Switch Symbol:
Revenue Growth Under Pressure
Below historical average.
Left:
||||
Year-over-year revenue growth rate
Latest
0.00%
↓ 100% below average
Average (22q)
31.02%
Historical baseline
Range
High:610.62%
Low:-100.00%
Volatility
2291.0%
High variability
| Period | Value |
|---|---|
| Q3 2025 | 0.00% |
| Q2 2025 | 0.00% |
| Q1 2025 | 0.00% |
| Q4 2024 | -100.00% |
| Q3 2024 | -95.07% |
| Q2 2024 | 610.62% |
| Q1 2024 | -49.13% |
| Q4 2023 | -2.22% |
| Q3 2023 | 138.13% |
| Q2 2023 | -48.39% |
| Q1 2023 | -28.01% |
| Q4 2022 | 56.92% |
| Q3 2022 | -23.34% |
| Q2 2022 | 48.84% |
| Q1 2022 | -1.67% |
| Q4 2021 | 39.43% |
| Q3 2021 | 140.46% |
| Q2 2021 | 26.84% |
| Q1 2021 | 0.00% |
| Q4 2020 | 0.00% |
| Q3 2020 | 0.00% |
| Q2 2020 | 0.00% |
| Q1 2020 | 0.00% |